Chronic hepatitis B virus (HBV) infection, defined as persistence of HBV surface antigen (HBsAg) for greater than 6 months, is a leading cause of chronic liver disease and death worldwide \[[@CIT0001]\]. In sub-Saharan Africa (SSA), the predominant mode of HBV transmission is horizontal, with a substantial number of infections acquired in early childhood \[[@CIT0002], [@CIT0003]\]. The estimated prevalence of chronic HBV infection in Kenya is 5.16% (95% confidence interval \[CI\], 4.86--5.48) \[[@CIT0004]\]. Twenty-five percent of human immunodeficiency virus (HIV)-1-uninfected individuals with chronic HBV are estimated to develop cirrhosis, hepatocellular carcinoma (HCC), or both \[[@CIT0001]\]. Approximately 40% of individuals who develop HBV-induced HCC in SSA do so before age 40 \[[@CIT0005]\]. Although universal childhood HBV vaccination has been provided in Kenya since the early 2000s, adult male sex workers and other men who have sex with men (MSM) are not routinely offered HBV vaccination.

Human immunodeficiency virus-1 incidence among MSM in Kenya has been estimated at 8--10 per 100 person years \[[@CIT0006], [@CIT0007]\], with estimates as high as 35.2 (95% CI, 23.8--52.1) per 100 person years among MSM only \[[@CIT0007]\]. Because HBV is more infectious than HIV-1 \[[@CIT0008]\], it may be expected that HBV incidence is substantial among Kenyan MSM. However, no data exist on HBV incidence in this group, despite the need for such data to support HBV vaccination programming targeting MSM \[[@CIT0009]\]. Therefore, we studied HBV incidence and associated risk factors for acquisition among initially HIV-1-negative, HBV-susceptible MSM enrolled in a cohort study in Coastal Kenya, all of whom were born before routine childhood vaccination began in Kenya.

METHODS {#s1}
=======

Study Design, Setting, and Population {#s2}
-------------------------------------

We retrospectively tested stored plasma samples from HIV-1-negative MSM aged 18--49 years who were enrolled into a HIV-1 vaccine feasibility cohort study between 2005 and 2014 in Coastal Kenya \[[@CIT0007]\]. All male cohort participants who reported anal sex with another man in the 3 months before enrollment and had stored blood samples available from enrollment and at least 1 follow-up visit through December 2014 were selected for the present study.

Cohort Procedures {#s3}
-----------------

Detailed cohort procedures are described elsewhere \[[@CIT0007]\]. In brief, enrollment and follow-up included a face-to-face interview using a standardized behavioral questionnaire, HIV-1 testing and counseling, medical history, and physical examination at each visit. Follow-up was quarterly, or monthly when receptive anal intercourse (RAI) was reported. Men who acquired HIV-1 during follow-up were offered enrollment into an acute infection cohort with quarterly follow-up visits during the first 2 years and 6-monthly visits thereafter \[[@CIT0010]\]. From May 25, 2009 onwards, HBV vaccination was provided to cohort participants as part of ongoing care and prevention services. Follow-up visits after the first documented HBV vaccination date were excluded from the study.

Laboratory Methods {#s4}
------------------

We tested archived samples using 3 HBV serological assays: Murex HBsAg version 3 (Diasorin) for HBsAg, ETI-AB-AUK-3 (Diasorin) for hepatitis B surface antibody (anti-HBs), and Murex anti-HBc (Diasorin) for hepatitis B core antibody (anti-HBc). We first tested the last available follow-up sample. If this last sample was negative for all 3 markers, we did no further testing for that participant, assuming they would have negative serologies at baseline. If the last available sample was positive for any of the 3 HBV markers, we also tested the baseline sample. Any available in-between samples were tested for anti-HBc or HBsAg if the baseline sample was negative for all 3 markers and the last available sample was positive for anti-HBc or HBsAg.

Definitions used for this study were as follows: (1) HBV-susceptible, negative for all the 3 HBV markers at baseline or during follow-up; (2) resolved HBV-infection, positive for anti-HBc, with or without anti-HBs, but negative for HBsAg at baseline; (3) acute or chronic HBV-infection, positive for HBsAg at baseline; (4) incident HBV-infection, negative for all 3 HBV markers at baseline and positive for anti-HBc or HBsAg during follow-up, following the approach of Falade et al \[[@CIT0011]\]); (5) possibly HBV-vaccinated, anti-HBs positive and negative for anti-HBc and HBsAg at baseline or during follow-up. The estimated date of infection for HBV was defined as the mid-point between a previously negative and subsequently positive anti HBc or HBsAg result \[[@CIT0008], [@CIT0011]\].

Detailed HIV-1 testing procedures are described elsewhere \[[@CIT0007]\]. In brief, HIV-1 testing was performed at each study visit using 2 rapid antibody test kits (Determine, Abbott Laboratories; Unigold, Trinity Biotech) in parallel. Discordant rapid HIV-1 test results were resolved using an enzyme-linked immunohsorbent assay (ELISA) test (Genetic System HIV-1/2 plus O EIA; Bio-Rad). All HIV-1-negative samples were tested for p24 antigen (Vironostika HIV-1 p24 ELISA; Biomérieux), and pre- and post-seroconversion samples were tested for HIV-1 ribonucleic acid (Amplicor Monitor 1.5; Roche).

Data Analysis and Statistical Methods {#s5}
-------------------------------------

We compared demographic and behavioral characteristics of men who returned for follow-up to those who did not return for follow-up after enrollment using Pearson's χ^2^ test. Hepatitis B virus-susceptible MSM were compared with MSM who had resolved, acute, or chronic HBV infection at baseline using Pearson's χ^2^ test, after excluding men whose serology results indicated possible HBV vaccination. Prevalence ratios were used to measure associations between participant characteristics and resolved, acute, or chronic HBV infection. We included factors associated with resolved, acute, or chronic HBV infection at *P* less than 0.2 in the bivariate analysis in a multivariable Poisson model to estimate adjusted prevalence ratios.

We included MSM who were HBV-susceptible at enrollment in the incidence analysis. The primary outcome was incident HBV infection, calculated as the number of seroconversions to a positive anti-HBc or HBsAg result divided by person-years of follow-up in each group of interest. Individual follow-up time was calculated from the date of study entry until the estimated date of incident HBV infection, the date of first documented HBV vaccine dose, or the date prior to an isolated positive anti-HBs result (i.e., possible HBV vaccination). We censored participants who were not vaccinated or became lost to follow-up at the last visit date in the study for which a stored sample was available for testing.

We evaluated potential risk factors that were fixed (demographics, baseline circumcision status) or time-dependent (genital washing, alcohol use, intravenous drug use, sexual behaviors, HIV status). Poisson models with robust standard errors were used to obtain population-averaged incidence rate ratios that accounted for correlation due to repeated measurements on the same subject over time. We included variables significant in bivariable analysis at *P* \< .2 and a priori predictors (associated with resolved, acute, or chronic HBV infection at enrollment in the univariate analysis) including age, marital status, sex work, RAI, and any unprotected sex, in an initial multivariable model of potential predictors of HBV acquisition. We then dropped variables with *P* \> .1 in this initial model that were not a priori predictors, to produce the final multivariable model. *P* values were 2-sided and significance was set at *P* ≤ .05. We used Stata 13.0 (StataCorp LP, College Station, TX) for analysis.

Ethical Considerations {#s6}
----------------------

The Kenya Medical Research Institute Ethics Review Committee approved the study. All participants provided written informed consent.

RESULTS {#s7}
=======

Study Population {#s8}
----------------

Of 908 MSM screened for cohort enrollment between 2005 and 2014, 133 (14.6%) were HIV-1 positive and excluded. Of the 775 HIV-1-negative men enrolled, 198 (25.5%) did not return for any follow-up.

Compared to MSM who remained in follow-up, MSM who were lost to follow up after the enrollment visit were younger (60.1% vs 45.1% were 18--24 years of age, *P* = .001), less likely to have been married (89.4% vs 79.7% were never married, *P* = .002), and more likely to report insertive anal intercourse (IAI) (68.2% vs 58.8%, *P* = .019) (data not shown).

Out of 577 HIV-1-negative MSM with at least 1 follow-up visit, 525 (91%) had enrollment and follow-up samples available for hepatitis B serology testing. Of these 525 MSM, 136 (25.9%) were classified as having resolved HBV infection, 42 (8.0%) as having acute or chronic HBV infection, and 35 (6.7%) as having possibly been vaccinated, because their serology was positive for anti-HBs only. A total of 312 (59.4%) were HBV susceptible at baseline (details for all participants in [Figure 1](#F1){ref-type="fig"}).

![Flow chart of men who have sex with men (MSM) cohort participants selected for hepatitis B virus (HBV) acquisition study, Kilifi, Kenya, 2005--2014. ^1^Missing either enrollment or follow-up sample. ^2^Defined as negative for HBV surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core antibody (anti-HBc) at baseline and positive for anti-HBc or HBsAg at any point during follow-up, regardless of whether exposure resulted in persistent HBV infection. ^3^Anti-HBs conversion without evidence of HBV exposure, possibly vaccinated outside our research cohort.](ofw25301){#F1}

Hepatitis B Virus Prevalence and Risk Factors {#s9}
---------------------------------------------

[Table 1](#T1){ref-type="table"} compares baseline demographic and behavioral characteristics of 312 HBV-susceptible and 178 MSM with resolved, acute, or chronic HBV-infections. Younger age, having never been married, sex work, RAI, and any unprotected sex were associated with HBV susceptibility. In multivariable analysis, only age remained statistically significantly associated with resolved, chronic, or acute HBV infection status, with younger men more likely to be HBV-susceptible (Supplemental Material, [Table 1](#T1){ref-type="table"}).

###### 

Baseline Demographic and Behavioral Characteristics of 490 HIV-1 Negative MSM in Kilifi, Kenya, 2005--2014

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                                                                  Overall (n = 490)   HBV-Susceptible\*\   Resolved, Acute, or Chronic HBV Infection\*\   *P* Value^†^                  
                                                                                                       (n = 312)            (n = 178)                                                                    
  -------------------------------------------------------------------------------- ------------------- -------------------- ---------------------------------------------- -------------- ----- -------- ------
  Age group (years)                                                                                                                                                                                      

  18--24                                                                           254                 (51.8)               178                                            (57.1)         76    (42.7)   .001

  25--34                                                                           188                 (38.4)               113                                            (36.2)         75    (42.1)   

  35+                                                                              48                  (9.8)                21                                             (6.7)          27    (15.2)   

  Education                                                                                                                                                                                              

  Primary/none                                                                     249                 (50.8)               149                                            (47.8)         100   (56.2)   .193

  Secondary                                                                        191                 (39.0)               130                                            (41.7)         61    (34.3)   

  Higher/tertiary                                                                  50                  (10.2)               33                                             (10.6)         17    (9.6)    

  Marital status                                                                                                                                                                                         

  Never married                                                                    405                 (82.7)               267                                            (85.6)         138   (77.5)   .024

  Ever married                                                                     85                  (17.3)               45                                             (14.4)         40    (22.5)   

  Religion                                                                                                                                                                                               

  Christian                                                                        234                 (47.8)               156                                            (50.0)         78    (43.8)   .405

  Muslim                                                                           146                 (29.8)               90                                             (28.8)         56    (31.5)   

  Other/none                                                                       110                 (22.4)               66                                             (21.2)         44    (24.7)   

  Employment                                                                                                                                                                                             

  None                                                                             203                 (41.4)               135                                            (43.3)         68    (38.2)   .504

  Self                                                                             218                 (44.5)               133                                            (42.6)         85    (47.8)   

  Formal                                                                           69                  (14.1)               44                                             (14.1)         25    (14.0)   

  Circumcised                                                                                                                                                                                            

  Yes                                                                              456                 (93.1)               294                                            (94.2)         162   (91.0)   .177

  Sex partners past 3 months                                                                                                                                                                             

  Men and women                                                                    306                 (62.4)               190                                            (60.9)         116   (65.2)   .348

  Men only                                                                         184                 (37.6)               122                                            (39.1)         62    (34.8)   

  Received payment for sex with cash, living expenses, or goods in past 3 months                                                                                                                         

  Yes                                                                              337                 (68.8)               225                                            (72.1)         112   (62.9)   .035

  Paid for sex in past 3 months                                                                                                                                                                          

  Yes                                                                              157                 (32.0)               98                                             (31.4)         59    (33.1)   .692

  Any use of alcoholic beverages in past month                                                                                                                                                           

  Yes                                                                              320                 (65.3)               206                                            (66.0)         114   (64.0)   .658

  Receptive anal intercourse (RAI) in past 3 months                                                                                                                                                      

  Yes                                                                              303                 (61.8)               203                                            (65.1)         100   (56.2)   .052

  Insertive anal intercourse (IAI) past in 3 months                                                                                                                                                      

  Yes                                                                              288                 (58.8)               183                                            (58.7)         105   (59.0)   .942

  Sexual exposure and protection with condom in past week                                                                                                                                                

  No activity                                                                      99                  (20.2)               61                                             (19.6)         38    (21.3)   .012

  All protected                                                                    90                  (18.4)               46                                             (14.7)         44    (24.7)   

  Any unprotected                                                                  301                 (61.4)               205                                            (65.7)         96    (53.9)   

  Total sex partners in past month                                                                                                                                                                       

  Less than 3                                                                      168                 (34.3)               101                                            (32.4)         67    (37.6)   .237

  Three or more                                                                    322                 (65.7)               211                                            (67.6)         111   (62.4)   

  Group sex in past 3 month                                                                                                                                                                              

  Yes                                                                              83                  (16.9)               52                                             (16.7)         31    (17.4)   .832

  Been raped in past 3 month                                                                                                                                                                             

  Yes                                                                              11                  (2.2)                6                                              (1.9)          5     (2.8)    .524

  Intravenous drug use in past 3 months                                                                                                                                                                  

  Yes                                                                              8                   (1.6)                4                                              (1.3)          4     (2.2)    .417

  Genital washing with soap in past week                                                                                                                                                                 

  Yes                                                                              399                 (81.4)               252                                            (80.8)         147   (82.6)   .619

  Sex with a menstruating female partner in past 3 months                                                                                                                                                

  Yes                                                                              51                  (10.4)               35                                             (11.2)         16    (9.0)    .490

  Don't know                                                                       2                   (0.4)                2                                              (0.6)          0     (0.0)    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: anti-HBc, hepatitis B core antibody; HBsAg, hepatitis B virus surface antigen; anti-HBs, hepatitis B surface antibody; HBV, hepatitis B virus; HIV, human immunodeficiency virus; MSM, men who have sex with men.

\*HBV-susceptible was defined as negative for all 3 HBV markers studied (HBsAg, anti-HBs, anti-HBc); resolved HBV infection was defined as positive for anti-HBc (with or without anti-HBs); and acute or chronic HBV-infection was defined as positive for HBsAg. We excluded participants who were positive for HBV surface antibody only, who were considered to have possibly received HBV vaccine.

^†^Two-sided value based on χ^2^ test for proportions.

Hepatitis B Virus Incidence and Risk Factors {#s10}
--------------------------------------------

Overall, we followed 312 MSM for a median of 8.4 months (interquartile range, 2.8--19.5) contributing 369.0 person-years. Twenty-two MSM converted for anti-HBc or HBsAg during follow-up, giving a crude HBV incidence rate of 6.0 (95% CI, 3.9--9.1) per 100 person-years. Of these, 5 (22.7%) acquired HIV-1 at a median of 30 months (range, 13--36 months) before acquiring HBV infection, whereas the remaining 17 (77.3%) acquired HBV while remaining HIV-1 seronegative. Of 27 men who acquired HIV-1 during follow-up, 4 started lamivudine or tenofovir-containing antiretroviral therapy (ART) during follow-up, at 24 to 55 months after HIV-1 acquisition. One of these 4 MSM converted for anti-HBc, at \~12 months after ART initiation.

In the multivariable analysis adjusted for age, marital status, sex work, RAI, and any unprotected sex, uncircumcised status (adjusted incidence rate ratio \[aIRR\], 5.0; 95% CI 1.5--16.8), recent HIV-1 acquisition (aIRR, 2.9; 95% CI 1.1--7.7), rape (5.0; 95% CI 1.2--20.4) and any tertiary education (aIRR, 3.2; 95% CI 1.1--9.7) were associated with HBV acquisition ([Table 2](#T2){ref-type="table"}). Results did not change when using a time-updated circumcision variable to capture the status of 1 man who was circumcised during follow-up (and remained HBV susceptible at his last visit). Of note, the unadjusted association between uncircumcised status and HBV infection was stronger among MSM reporting IAI (incidence rate ratio \[IRR\], 4.6; 95% CI 1.0--20.4) than among men not reporting IAI (IRR, 3.5; 95% CI 0.9--14.3). The 8 incident HBV cases among men reporting RAI all occurred in circumcised MSM.

###### 

Risk Factors Associated With HBV Incidence Among 312 MSM in Kilifi, Kenya, 2005--2014

  Characteristics                                                                     Incident HBV/100 PY\*   Incidence/100 PY (95% CI)   Unadjusted IRR (95% CI)   *P* Value   Adjusted IRR (95% CI)   *P* Value
  ----------------------------------------------------------------------------------- ----------------------- --------------------------- ------------------------- ----------- ----------------------- -----------
  Age categories (years)†                                                                                                                                                                               
   18--24                                                                             12/204.4                5.9 (3.3-10.3)              Reference                             Reference               
   25--34                                                                             9/133.4                 6.7 (3.5-13.0)              1.15 (0.48-2.75)          .755        1.09 (0.46-2.57)        .840
   35+                                                                                1/31.3                  3.2 (0.4--22.7)             0.54 (0.07-4.33)          .564        0.74 (0.11-4.89)        .752
  Education                                                                                                                                                                                             
   Primary/none                                                                       9/185.0                 4.9 (2.5-9.4)               Reference                             Reference               
   Secondary                                                                          9/160.9                 5.6 (2.9-10.8)              1.15 (0.46-2.92)          .762        1.00 (0.41-2.45)        .998
   Higher/tertiary                                                                    4/23.2                  17.2 (6.5-45.9)             3.56 (1.15-11.00)         .027        3.18 (1.05-9.65)        .041
  Marital status†                                                                                                                                                                                       
   Never married                                                                      20/303.3                6.6 (4.3-10.2)              Reference                             Reference               
   Ever married                                                                       2/65.7                  3.0 (0.8--12.2)             0.46 (0.10-2.02)          .303        0.51 (0.12-2.08)        .346
  Religion                                                                                                                                                                                              
   None/other                                                                         3/51.0                  5.9 (1.9-18.2)              Reference                             --                      --
   Christian                                                                          14/184.9                7.6 (4.5-12.8)              1.29 (0.36-4.66)          .700                                
   Muslim                                                                             5/133.1                 3.8 (1.6-9.0)               0.64 (0.14-2.80)          .549                                
  Employment                                                                                                                                                                                            
   None                                                                               11/165.1                6.7 (3.7-12.0)              Reference                             --                      --
   Self                                                                               8/138.6                 5.8 (2.9-11.5)              0.87 (0.35-2.16)          .764                                
   Formal                                                                             3/65.3                  4.6 (1.5-14.2)              0.69 (0.18-2.57)          .578                                
  Circumcised                                                                                                                                                                                           
   Yes                                                                                18/349.4                5.2 (3.2-8.2)               Reference                             Reference               
   No                                                                                 4/19.6                  20.4 (7.7-54.3)             4.00 (1.44-11.08)         .008        4.96 (1.47-16.75)       .010
  HIV-1 status                                                                                                                                                                                          
   Seronegative                                                                       17/325.2                5.2 (3.2-8.4)               Reference                             Reference               
   Recent HIV acquisition (range, 13--36 months)                                      5/43.8                  11.4 (4.8-27.4)             2.19 (0.83-5.74)          .111        2.88 (1.08-7.67)        .035
  Sex partners past 3 months                                                                                                                                                                            
   Men and women                                                                      15/252.2                5.9 (3.6-9.9)               Reference                             --                      --
   Men only                                                                           7/116.8                 6.0 (2.9-12.6)              1.01 (0.41-2.48)          .989                                
  Received payment for sex with cash, living expenses, or goods in past 3 months^†^                                                                                                                     
   No                                                                                 11/159.6                6.9 (3.8-12.4)              Reference                             Reference               
   Yes                                                                                11/209.4                5.3 (2.9-9.5)               0.76 (0.32-2.81)          .538        0.75 (0.31-1.85)        .537
  Paid for sex in past 3 months                                                                                                                                                                         
   No                                                                                 16/261.3                6.1 (3.8-10.0)              Reference                             --                      --
   Yes                                                                                6/107.7                 5.6 (2.5-12.4)              0.91 (0.35-2.35)          .846                                
  Any use of alcoholic beverage in past month                                                                                                                                                           
   No                                                                                 10/139.4                7.2 (3.9-13.3)              Reference                             --                      --
   Yes                                                                                12/229.6                5.2 (3.0-9.2)               0.73 (0.31-1.73)          .475                                
  Receptive anal intercourse (RAI) in past 3 months^†^                                                                                                                                                  
   No                                                                                 14/203.8                6.9 (4.1-11.6)              Reference                             Reference               
   Yes                                                                                8/165.2                 4.8 (2.4-9.7)               0.70 (0.30-1.67)          .426        0.46 (0.19-1.13)        .091
  Insertive anal intercourse (IAI) in past 3 months^‡^                                                                                                                                                  
   No                                                                                 12/180.5                6.6 (3.8-11.7)              Reference                             --                      --
   Yes                                                                                10/188.5                5.3 (2.9-9.9)               0.80 (0.34-1.86)          .601                                
  Sexual exposure and protection with condoms in past week^†^                                                                                                                                           
   No activity                                                                        6/120.3                 5.0 (2.2-11.1)              Reference                             Reference               
   All protected                                                                      6/108.7                 5.5 (2.5-12.3)              1.11 (0.36-3.43)          .859        1.42 (0.45-4.53)        .549
   Any unprotected                                                                    10/140.0                7.1 (3.8-13.3)              1.44 (0.51-4.00)          .490        2.06 (0.67-6.34)        .208
  Total sex partners in past month                                                                                                                                                                      
   Less than 3                                                                        11/192.4                5.7 (3.2-10.3)              Reference                             --                      --
   Three or more                                                                      11/176.6                6.2 (3.4-11.2)              1.09 (0.48-2.48)          .838                                
  Group sex in past 3 months^‡^                                                                                                                                                                         
   No                                                                                 18/333.2                5.4 (3.4-8.6)               Reference                                                     
   Yes                                                                                4/35.9                  11.2 (4.2-29.7)             2.06 (0.69-6.15)          .196                                
  Raped in past 3 months                                                                                                                                                                                
   No                                                                                 21/364.5                5.8 (3.8-8.8)               Reference                             Reference               
   Yes                                                                                1/4.5                   22.0 (3.1--156.2)           3.82 (0.92-15.80)         .064        4.95 (1.20-20.42)       .027
  Intravenous drug use in past 3 months                                                                                                                                                                 
   No                                                                                 22/368.0                6.0 (3.9-9.1)               --                        --          --                      --
   Yes                                                                                0/1.0                   0                                                                                         
  Genital washing with soap in past week^‡^                                                                                                                                                             
   No                                                                                 7/71.2                  9.8 (4.7-20.6)              Reference                             --                      --
   Yes                                                                                15/297.8                5.0 (3.0-8.4)               0.51 (0.21-1.25)          .140                                
  Sex with a menstruating female partner in past 3 months                                                                                                                                               
   No                                                                                 20/341.0                5.9 (3.8-9.1)               Reference                             --                      --
   Yes                                                                                1/24.9                  4.0 (0.6--28.5)             0.68 (0.09-5.01)          .701                                
   Don't know                                                                         1/3.1                   32.2 (4.5-228.7)            5.49 (0.67-44.96)         .113                                

Abbreviations: aIRR, adjusted incidence rate ratios; CI, confidence interval; anti-HBc, hepatitis B core antibody; HBsAg, hepatitis B virus surface antigen; anti-HBs, hepatitis B surface antibody; HBV, hepatitis B virus; HIV-1, human immunodeficiency virus; IRR, incidence rate ratios; MSM, men who have sex with men; PY, person-years.

\*Incident HBV infection was defined as being negative for HBsAg, anti-HBs, and anti-HBc at baseline and positive for anti-HBc or HBsAg at any point during follow-up, regardless of whether exposure resulted in persistent HBV infection.

^†^Considered a priori in the initial multivariable model.

^‡^Not included in the final model.

DISCUSSION {#s11}
==========

In this population of MSM in coastal Kenya, approximately 60% were susceptible to HBV infection at enrollment. Susceptible men were young and reported high-risk sexual behavior that put them at risk for both HIV-1 and HBV acquisition. We found an overall incidence of HBV core or HBsAg seroconversion of 6.0 per 100 person-years. Recent HIV-1 acquisition, having been raped and any tertiary education were strongly associated with HBV acquisition risk, whereas circumcised MSM had lower HBV acquisition rates.

A high HBV incidence was observed in our cohort among MSM compared with that reported in the Multicenter AIDS Cohort Study (MACS) cohort in the United States (\~0.96 per 100 person-years) \[[@CIT0011]\] and in Amsterdam (\~1.0--2.0 per 100 person-years) \[[@CIT0008]\]. Of note, 31% of men in the MACS study had received at least 1 dose of HBV vaccine, increasing to 60% by the end of the observation period. In our analysis, we excluded men positive for anti-HBs only at baseline and censored initially HBV-susceptible men at their first HBV vaccine dose, so our higher estimate reflects HBV incidence in an unvaccinated cohort.

The HBV acquisition risk in this study was 5-fold higher in those who were uncircumcised compared with circumcised MSM. To the best of our knowledge, our study is the first to report an association between HBV acquisition risk and lack of circumcision among MSM in Africa. A cross-sectional study conducted among MSM from Argentina showed no significant association between male circumcision and prior HBV infection, defined as a positive HBsAg or anti-HBc test, either overall or among MSM who reported no RAI \[[@CIT0012]\]. Some studies of the association between circumcision status and HBV infection in other populations have reported an increased risk of HBV due to circumcision as one of several unsafe medical procedures or traditional practices examined \[[@CIT0013]\]. It is possible that safe surgical removal of the foreskin reduces sexual HBV acquisition through similar mechanisms as for HIV-1 infection \[[@CIT0014]\]. That no association has been found between circumcision and prevalent HBV infection in studies in SSA could be explained by the large number of HBV infections acquired during childhood \[[@CIT0003]\] and the failure to evaluate HBV acquisition prospectively. Our finding that circumcision may protect against HBV acquisition needs verification in other populations with sexual HBV acquisition risk, including uncircumcised men who report IAI.

Men who have sex with men who had acquired HIV-1 in the past 1--3 years were 3-fold more likely to acquire HBV compared with men who remained HIV-1 negative during follow-up. This is consistent with a cohort study conducted among MSM in the United States that documented higher rates of incident HBV (defined as positive HBsAg or anti-HBc results during follow-up) in men who were HIV-infected at baseline, compared with men without HIV infection at baseline \[[@CIT0011]\]. In that study, individuals who acquired HIV-1 during follow-up were reclassified as HIV-infected and not categorized separately as having recent HIV-1 acquisition. Although the strong association of HBV acquisition with recent HIV-1 acquisition in our study of initially HIV-1-negative men remained after adjusting for sexual risk behavior, it may be possible that men who acquired HIV-1 during follow-up were at higher risk for sexual HBV acquisition due to unmeasured confounders. In our study, most MSM who acquired HIV-1 were not immediately treated with ART because Kenyan guidelines during the study period required a CD4 count of 350 or below to initiate therapy. In future prospective studies in which HIV-1-positive men will be immediately treated, it is likely that HBV risk will be reduced \[[@CIT0015]\].

We observed a 5-fold higher risk of HBV acquisition among men who were raped. Because there was only 1 event among men who reported rape, CIs for the risk estimate were wide; however, it is plausible that damage to mucosal surfaces during rape may enhance HBV acquisition.

The rate of HBV infection among men with any tertiary education was 3 times that of MSM with primary or no formal education. Of note, a lower proportion of MSM with tertiary education reported any unprotected sex compared to MSM with lower education (15.2% vs. 38.0%, *P* = .008) (data not shown). The association we report between HBV risk and tertiary education may be due to under-reporting of sexual risk behavior among MSM with tertiary education, or to unmeasured confounders.

This study had 3 main limitations. First, self-reported sexual behavior may have been subject to recall bias, and social desirability bias may have led to underreporting of risky sexual behavior resulting to reduced effect sizes. Second, our sample and the number of HBV acquisition events were small. This likely reduced power and affected our ability to test multiple associations. Third, the MSM we studied are not representative of all Kenyan MSM; they all reported high-risk sexual behavior and most participated in transactional sex. Thus, the HBV incidence we observed may overestimate HBV incidence among MSM in Kenya.

Universal childhood HBV vaccination was introduced in Kenya in 2002 \[[@CIT0016]\]. However, MSM born before this date did not receive HBV vaccination during childhood and hence are susceptible to HBV infection later in life. They and other at-risk populations such as female sex workers and injection drug users should be targeted for HBV vaccination.

CONCLUSIONS {#s12}
===========

In conclusion, we documented high HBV acquisition rates among MSM in Coastal Kenya, associated with recent HIV-1 acquisition, uncircumcised status rape, and tertiary education. Kenyan MSM who are at high risk for HIV-1 acquisition and for rape \[[@CIT0017]\] should be prioritized for HBV vaccination. Given our findings on decreased HBV-infection risk in circumcised men, consideration should also be given to the promotion of circumcision among MSM who report IAI.
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Supplementary materials are available at *Open Forum Infectious Diseases* online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.
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